Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Shine

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Clinical Chemistry|January 20, 2011
Gene targeting through o-methylated catecholamine metabolite patternsBrian Shine
Annals of Clinical Biochemistry|August 30, 2008
Use of routine clinical laboratory data to define reference intervalsBrian Shine
Annals of Clinical Biochemistry|September 7, 2018
Big data in clinical biochemistryBrian Shine, Julian H Barth
BMJ Open|August 1, 2019
In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain modelsBrian Shine, Tim James, Amanda Adler
British Journal of Clinical Pharmacology|September 10, 2016
Therapeutic drug monitoring in the era of precision medicine: opportunities!Serge Cremers, Nishan Guha, Brian Shine
Lancet (London, England)|March 21, 2006
Renoprotective effects of renin-angiotensin-system inhibitorsAmanda Adler, Irene Stratton, Brian Shine
Clinical Chemistry|September 23, 2006
Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral populationKeith L Brain, Jonathan Kay, Brian Shine
Annals of Clinical Biochemistry|March 20, 2023
Exclusion criteria for reference studies: Context is keySamuel Dockree, Brian Shine, Tim James, et al.
Annals of Clinical Biochemistry|November 3, 2022
Pregnancy-specific reference intervals: should we exclude women based on body mass index?Samuel Dockree, Brian Shine, Tim James, et al.
BMJ Open|December 21, 2011
Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reportingChristopher A O'Callaghan, Brian Shine, Daniel S Lasserson
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Clinical Chemistry|January 20, 2011
Gene targeting through o-methylated catecholamine metabolite patternsBrian Shine
Annals of Clinical Biochemistry|August 30, 2008
Use of routine clinical laboratory data to define reference intervalsBrian Shine
Annals of Clinical Biochemistry|September 7, 2018
Big data in clinical biochemistryBrian Shine, Julian H Barth
BMJ Open|August 1, 2019
In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain modelsBrian Shine, Tim James, Amanda Adler
British Journal of Clinical Pharmacology|September 10, 2016
Therapeutic drug monitoring in the era of precision medicine: opportunities!Serge Cremers, Nishan Guha, Brian Shine
Lancet (London, England)|March 21, 2006
Renoprotective effects of renin-angiotensin-system inhibitorsAmanda Adler, Irene Stratton, Brian Shine
Clinical Chemistry|September 23, 2006
Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral populationKeith L Brain, Jonathan Kay, Brian Shine
Annals of Clinical Biochemistry|March 20, 2023
Exclusion criteria for reference studies: Context is keySamuel Dockree, Brian Shine, Tim James, et al.
Annals of Clinical Biochemistry|November 3, 2022
Pregnancy-specific reference intervals: should we exclude women based on body mass index?Samuel Dockree, Brian Shine, Tim James, et al.
BMJ Open|December 21, 2011
Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reportingChristopher A O'Callaghan, Brian Shine, Daniel S Lasserson
Pageof 10